- Correction
- Open access
- Published:
Correction: Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA
Molecular Cancer volume 23, Article number: 195 (2024)
The Original Article was published on 14 September 2020
Correction: Mol Cancer 19, 143 (2020)
Recently in a re-examination of our previously published paper [1], “Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA” [Molecular Cancer 19, article number 143 (2020)], we found two errors.
The first error is that we presented the wrong primer sequences for GAPDH in the Supplemental Methods (in the Additional file 2). We mistakenly listed the primer sequences for human β-actin (ACTB) as for GAPDH. The correct primer sequences for GAPDH are 5′-AATGAAGGGGTCATTGATGG − 3′ and 5′-AAGGTGAAGGTCGGAGTCAA − 3′. These were used in this study. Please find the resized Additional file 2 in the attachment.
The other error is a misplaced western blot image for the loading control β-actin in Fig. 4e. We have identified the correct image for β-actin bands. The following is the corrected figure.
They are minor errors, and their correction does not affect the conclusion of this article, however, we sincerely apologize to the readers and editors for the inconvenience caused by our mistakes. We would like to ask for an opportunity to publish this correction.
References
Kang M, Tang B, Li J, et al. Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol Cancer. 2020;19:143. https://doi.org/10.1186/s12943-020-01248-9.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12943-020-01248-9.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Additional file 2.
This section describes the details of experimental procedures and materials that are not described in the Method Section, including Supplemental methods and lists of primers, antibodies, and plasmids.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kang, M., Tang, B., Li, J. et al. Correction: Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol Cancer 23, 195 (2024). https://doi.org/10.1186/s12943-024-02111-x
Published:
DOI: https://doi.org/10.1186/s12943-024-02111-x